n-formyl-13-dihydrocarminomycin has been researched along with Acute Myelogenous Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blaise, D; Chen, J; Ciceri, F; Gorin, NC; Gulbas, Z; Houhou, M; Huang, H; Koc, Y; Labopin, M; Li, L; Luo, Y; Mohty, M; Polge, E; Wu, D; Ye, Y; Zhang, X | 1 |
1 other study(ies) available for n-formyl-13-dihydrocarminomycin and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Similar outcomes following non-first-degree and first-degree related donor haploidentical hematopoietic cell transplantation for acute leukemia patients in complete remission: a study from the Global Committee and the Acute Leukemia Working Party of the E
Topics: Acute Disease; Adult; Bone Marrow; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retrospective Studies; Transplantation Conditioning | 2023 |